Welcome!
Welcome to Aclepsa Discount Generic Pharmacy, your one-stop destination for affordable high-quality medications.
We carry a very large selection of generic medications. We stock generic equivalents of US FDA approved prescription drugs through our fully-licensed overseas pharmacy.
Why order from Aclepsa:
- Save up to 70% off retail prices by ordering online
- Everyday low medication prices
- On-line real-time order tracking from our pharmacy to your doorstep
- Strict medication quality standards
- Over 1100 different drug products in stock
- 24x7 customer support
- Order as many products as you like and never pay a shipping fee.
We have one function and one function only, to save you money on your medication.
We provide top-quality products, world-class customer service, excellent value for money, and we welcome your feedback.
Try us - you will not be disappointed!
Full Drug List
List Drugs by First Letter
Click on a letter to get a list of drug names starting with that letter:
List Drugs by Name
Enter all or part of the name of the drug you are looking for:
Contact Us
By phone, live chat, e-mail, or callback request with questions about drug availability.
New! Call our expanded customer support center toll-free at
1-866-978-4944,
7 AM - 9 PM EST Mon - Fri, 9 AM - 5 PM EST Sat - Sun.
Free Shipping!
Shipping is free regardless of destination. There are no dispensing fees, membership fees, or any other hidden fees. Orders are sent by Registered Air Mail. Delivery time to the USA is typically 10 business days after we have sent the order, though it can take longer.
FDA Drug News
FDA MedWatch
FDA MedWatch Safety Alerts
http://www.fda.gov/medwatch
en-us
Mon, 25 Aug 2008 15:22:00 EDT
jay.wattenberg@fda.hhs.gov
Tysabri (natalizumab)
Neurologists, other healthcare professionals, patients
Two new cases of progressive multifocal leukoencephalopathy in European patients receiving Tysabri as monotherapy for multiple sclerosis for more than one year.
Mon, 25 Aug 2008 15:22:00 EDT
http://www.fda.gov/medwatch/safety/2008/safety08.htm#Tysabri2
http://www.fda.gov/medwatch/safety/2008/safety08.htm#Tysabri2
Ezetimibe/Simvastatin (Vytorin); Simvastatin (Zocor); and Ezetimibe (Zetia)
Endocrinologists, cardiologists, other healthcare professionals, patients
Report of SEAS trial of a possible association between the use of Vytorin and a potential increased incidence of cancer.
Thu, 21 Aug 2008 19:55:00 EDT
http://www.fda.gov/medwatch/safety/2008/safety08.htm#ezetimibe2
http://www.fda.gov/medwatch/safety/2008/safety08.htm#ezetimibe2
Byetta (exenatide)
Endocrinologists, other healthcare professionals, consumers
UPDATE - Since October 2007, FDA has received reports of 6 cases of hemorrhagic or necrotizing pancreatitis in patients in taking Byetta.
Thu, 21 Aug 2008 10:56:00 EDT
http://www.fda.gov/medwatch/safety/2007/safety07.htm#Byetta
http://www.fda.gov/medwatch/safety/2007/safety07.htm#Byetta
July 2008 Monthly Safety Labeling
Healthcare professionals
Summary of safety-related revisions to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS sections of the Prescribing Information, plus Patient Package Inserts and Medication Guides.
Thu, 14 Aug 2008 12:45:00 EDT
http://www.fda.gov/medwatch/safety/2008/jul08_quickview.htm
http://www.fda.gov/medwatch/safety/2008/jul08_quickview.htm
Boston Scientific NexStent Monorail, NexStent Carotid Stent and Monorail Delivery System
Cardiologists, hospital risk managers
Product recalled because the tip of the stent delivery system may detach during a carotid artery stenting procedure.
Thu, 14 Aug 2008 11:45:00 EDT
http://www.fda.gov/medwatch/safety/2008/safety08.htm#NexStent
http://www.fda.gov/medwatch/safety/2008/safety08.htm#NexStent
Vivitrol (naltrexone)
Primary healthcare physicians, internists, other healthcare professionals
Serious injection site reactions may occur with the use of injectable naltrexone.
Tue, 12 Aug 2008 14:55:00 EDT
http://www.fda.gov/medwatch/safety/2008/safety08.htm#naltrexone
http://www.fda.gov/medwatch/safety/2008/safety08.htm#naltrexone
Fentanyl Transdermal System CII Patches
Pain management specialists, risk managers, other healthcare professionals, patients
UPDATE - Voluntary recall because one lot of the product contained patches leaking fentanyl gel.
Tue, 12 Aug 2008 14:55:00 EDT
http://www.fda.gov/medwatch/safety/2008/safety08.htm#Fentanyl
http://www.fda.gov/medwatch/safety/2008/safety08.htm#Fentanyl
Erythropoiesis Stimulating Agents (ESAs) - Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp)
Oncologists, other healthcare professionals
UPDATE - Dear Healthcare Professional letter added.
Fri, 08 Aug 2008 10:30:00 EDT
http://www.fda.gov/medwatch/safety/2008/safety08.htm#ESA2
http://www.fda.gov/medwatch/safety/2008/safety08.htm#ESA2
Simvastatin Used With Amiodarone
Cardiologic healthcare professionals, pharmacists, other healthcare professionals
Risk of rhabdomyolysis when simvastatin is used with amiodarone, particularly with simvastatin doses greater than 20 mg daily.
Fri, 08 Aug 2008 10:30:00 EDT
http://www.fda.gov/medwatch/safety/2007/safety07.htm#Simvastatin
http://www.fda.gov/medwatch/safety/2007/safety07.htm#Simvastatin
Desmopressin Acetate (marketed as DDAVP Nasal Spray, DDAVP Rhinal Tube, DDAVP, DDVP, Minirin, and Stimate Nasal Spray)
Endocrinologists, pediatricians, other healthca